New research shows how much poor countries must expect to be supplied with anti - vaccines - CO VID

Just over half of all planned doses of coronary vaccines were purchased from high-income countries such as the United States, Japan, and Australia, meaning that a quarter of the world's population will not be vaccinated until 2022, researchers reported.

These rich countries have publicly ordered close to 7.5 billion doses of Cavid-19 vaccines, enough to vaccinate 3.76 billion people, the Johns Hopkins Bloomberg University finds.

By the time the report was written, the U.S. counted one fifth of all global cases, Covid-19 but had reserved 800 million doses of the vaccine. Japan and Australia made up less than 1% of the cases, but they had divided one billion doses.

Researchers predicted that 13 leading producers of vaccines working in coronary vaccines have the potential capacity for about 6 billion vaccines by the end of 2021.

“Pak more than half (51%) of these doses will go to high-income countries, which represent 14% of the world's population. Low- and medium-income countries have the rest, despite those countries that make up more than 85% of the world's population “, they write in their report, published in the BMJ.

Even if all these vaccine producers succeeded in achieving their maximum production capacity, at least one fifth of the world's population would not have access to vaccines by 2022. ”

However, there is an effort to avoid that. COVAX, co-ordinated by the World Health Organization, the Gavi's global vaccine initiative, and the Coalition for Epidemiological Efficiency Innovations (CEPI), is trying to build production capacity for 2 billion doses of coronary vaccine. / A2 CNN